Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats

Journal of Nutrition

Volumn 135, Issue 4, 2005, Pages 714-721

  Fu, Wenjiang J ^a   Haynes, Tony E ^a   Kohli, Ripla ^a   Hu, Jianbo ^a   Shi, Wenjuan ^a   Spencer, Thomas E ^a   Carroll, Raymond J ^a   Meininger, Cynthia J ^b   Wu, Guoyao ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Arginine; Diabetes; Gene expression; Nitric oxide; Obesity

Indexed keywords

ARGININE; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ABDOMEN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA MICROARRAY; ENZYME ACTIVATION; EPIDIDYMIS; GENETIC ANALYSIS; LIPID OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; RAT; RAT STRAIN;

ANIMALIA;

EID: 16244412330     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.4.714     Document Type: Article

References (53)

1. Hill, J. O., Wyatt, H. R., Reed, G. W. & Peters, J. C. (2003) Obesity and the environment: where do we go from here. Science (Washington, DC) 299: 853-855.
2. Abelson, P. & Kennedy, D. (2004) The obesity epidemic. Science (Washington, DC) 304: 1413.
3. Bell, A. C., Ge, K. & Popkin, B. M. (2001) Weight gain and its predictors in Chinese adults. Int. J. Obes. 25: 1079-1086.
4. Pi-Sunyer, X. (2003) A clinical view of the obesity problem. Science (Washington, DC) 299: 859-860.
5. Fabricatore, A. N. & Wadden, T. A. (2003) Treatment of obesity: an overview. Clin. Diabetes 21: 67-72.
6. Wu, G. & Morris, S. M., Jr. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336: 1-17.
7. Garcia-Villafranca, J., Guillen, A. & Castro, J. (2003) Involvement of nitric oxide/cyclic GMP signaling pathway in the regulation of fatty acid metabolism in rat hepatocytes. Biochem. Pharmacol. 65: 807-812.
8. Wu, Z. D., Puigserver, P., Andersson, U., Zhang, C. Y., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C. & Spiegelman, B. M. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
9. Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M. & Kelly, D. P. (2000) Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Investig. 106: 847-856.
10. Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S. & Carruba, M. O. (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (Washington, DC) 299: 896-899.
11. Khedara, A., Goto, T., Morishima, M., Kayashita, J. & Kato, N. (1999) Elevated body fat in rats by the dietary nitric oxide synthase inhibitor, L-Nω-nitroarginine. Biosci. Biotechnol. Biochem. 63: 698-702.
12. Gaudiot, N., Jaubert, A. M., Charbonnier, E., Sabourault, D., Lacasa, D., Giudicelli, Y. & Ribiere, C. (1998) Modulation of white adipose tissue lipolysis by nitric oxide. J. Biol. Chem. 273: 13475-13481.
13. Lincova, D., Misekova, D., Kmonickova, E., Canova, N. & Farghali, H. (2002) Effect of nitric oxide donors on isoprenaline-induced lipolysis in rat epididymal adipose tissue: studies in isolated adipose tissues and immobilized perfused adipocytes. Physiol. Res. 51: 387-394.
14. Khedara, A., Kawai, Y., Kayashita, J. & Kato, N. (1996) Feeding rats the nitric oxide synthase inhibitor, L-Nω-nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation. J. Nutr. 126: 2563-2567.
15. Kurowska, E. M. & Carroll, K. K. (1998) Hypochelesterolemic properties of nitric oxide: in vivo and in vitro studies using nitric oxide donors. Biochim. Biophys. Acta 1392: 41-50.
16. Gaudiot, N., Ribiere, C., Jaubert, A. M. & Giudicelli, Y. (2000) Endogenous nitric oxide is implicated in the regulation of lipolysis through antioxidant-related effect. Am. J. Physiol. 279: C1603-C1610.
17. Fruhbeck, G. & Gomez-Ambrosi, G. (2001) Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal. 13: 827-833.
18. Clark, J., Palmer, C. J. & Shaw, W. N. (1983) The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol. Med. 173: 68-75.
19. Pieper, G. M. (1998) Review of alterations in endothelial nitric oxide production in diabetes. Hypertension 31: 1047-1060.
20. Kohli, R., Meininger, C. J., Haynes, T. E., Yan, W., Self, J. T. & Wu, G. (2004) Dietary L-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic rats. J. Nutr. 134: 600-608.
21. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44: 360-364.
22. Li, H., Meininger, C. J. & Wu, G. (2000) Rapid determination of nitrite by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 746: 199-207.
23. Wu, G., Knabe, D. A. & Flynn, N. E. (1994) Synthesis of citrulline from glutamine in pig enterocytes. Biochem. J. 299: 115-121.
24. - on ketogenesis in perfused rat liver. Am. J. Physiol. 261: E221-E226.
25. Laurell, S. & Tibling, G. (1966) An enzymatic fluorometric micromethod for the determination of glycerol. Clin. Chim. Acta 13: 317-322.
26. Hu, J., Gray, A. & Spencer, T. E. (2004) Gene expression profiling of neonatal mouse uterine development. Biol. Reprod. 70: 1870-1876.
27. Stewart, M. D., Johnson, G. A., Gray, C. A., Burghardt, R. C., Schuler, L. A., Joyce, M. M., Bazer, F. W. & Spencer, T. E. (2000) Prolactin receptor and uterine milk protein expression in the ovine endometrium during the estrous cycle and pregnancy. Biol. Reprod. 62: 1779-1789.
28. Liang, K. Y. & Zeger, S. L. (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
29. Kerr, M. K., Afshari, C. A., Bennett, L., Bushel, P., Martinez, J., Walker, N. J. & Churchill, G. A. (2002) Statistical analysis of a gene expression microarray experiment with replication. Stat. Sin. 12: 203-217.
30. Benjamini, Y. & Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57: 289-300.
31. Unger, R. H. & Orci, L. (2001) Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15: 312-321.
32. Meininger, C. J., Cai, S., Parker, J. L., Channon, K. M., Kelly, K. A., Becker, E. J., Wood, M. K. & Wu, G. (2004) GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. FASEB J. 18: 1900-1902.
33. Beck, B., Richy, S. & Stricker-Krongrad, A. (2004) Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sci. 76: 473-478.
34. Gilbert, M., Magnan, C., Turban, S., Andre, J. & Guerre-Millo, M. (2003) Leptin receptor-deficient obese Zucker rats reduce their food intake in response to a systemic supply of calories from glucose. Diabetes 52: 277-282.
35. Napoli, C., Williams-Ignarro, S., de Nigris, F., Lerman, L. O., Rossi, L., Guarino, C., Mansueto, G., Di Tuoro, F., Pignalosa, O., De Rosa, G., Sica, V. & Ignarro, L. J. (2004) Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U.S.A. 101: 8797-8802.
36. Wu, G. & Meininger, C. J. (2002) Regulation of nitric oxide synthesis by dietary factors. Annu. Rev. Nutr. 22: 61-86.
37. Paddon-Jones, D., Borsheim, E. & Wolfe, R. R. (2004) Potential ergogenic effects of arginine and creatine supplementation. J. Nutr. 134: 2888S-2894S.
38. Oberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B. & Patsch, W. (2004) Complex haplotypes of the PGC-1α gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53: 1385-1393.
39. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M. J., Patterson, N., Mesirov, J. P., Golub, T. R., Tamayo, P., Spiegelman, B. M., Lander, E. S., Hischhorn, J. N., Altshuler, D. & Groop, L. C. (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34: 267-273.
40. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R. & Mandarino, L. J. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100: 8466-8471.
41. Hardie, D. G. & Pan, D. A. (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30: 1064-1070.
42. Tomas, E., Kelly, M., Xiang, X. Q., Tsao, T. S., Keller, C., Keller, P., Luo, Z. J., Lodish, H., Saha, A. K., Unger, R. & Ruderman, N. B. (2004) Metabolic and hormonal interactions between muscle and adipose tissue. Proc. Nutr. Soc. 63: 381-385.
43. Sengenes, C., Bouloumie, A., Hauner, H., Berlan, M., Busses, R., Lafontan, M. & Galitzky, J. (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem. 278: 48617-48626.
44. Ignarro, L. J., Buga, G. M., Wei, L. H., Bauer, P. M., Wu, G. & del Soldato, P. (2001) Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 98: 4202-4208.
45. Maines, M. D. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554.
46. Morita, T., Perrella, M. A., Lee, M. E. & Kourembanas, S. (1995) Smooth muscle cell-derived carbon monoxide is a regulator of cGMP. Proc. Natl. Acad. Sci. U.S.A. 92: 1475-1479.
47. Miguez, I., Marino, G., Rodriguez, B. & Taboada C. (2004) Effects of dietary L-arginine supplementation on serum lipids and intestinal enzyme activities in diabetic rats. J. Physiol. Biochem. 60: 31-38.
48. Mendez, J. D. & Balderas, F. (2001) Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats. Biochemie 83: 453-458.
49. Flynn, N. E., Meininger, C. J., Haynes, T. E. & Wu, G. (2002) The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother. 56: 427-438.
50. Wu, G. & Meininger, C. J. (2000) Arginine nutrition and cardiovascular function. J. Nutr. 130: 2626-2629.
51. Maxwell, A. J. & Cooke, J. P. (2001) L-Arginine: its role in cardiovascular therapy. In: Nitric Oxide and the Cardiovascular System (Loscalzo, J. & Vita, J. A. eds.), pp. 547-585. Humana Press, Totowa, NJ.
52. White, J. R., Jr., Davis, S. N., Coopan, R., Davidson, M. B., Mulcahy, K., Manko, G. A. & Nelinson, D. (2003) Clarifying the role of insulin in type 2 diabetes management. Clin. Diabetes 21: 14-21.
53. Huynh, N. T. & Tayek, J. A. (2002) Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation. J. Am. Coll. Nutr. 21: 422-427.